Tag Archives: Rational use

British Parliamentary Inquiry: “Lariam Should be ‘Drug of Last Resort’ for Troops”

  Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee, in its report on the MoD’s use of the drug. Report: An acceptable risk? The use … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , , | Leave a comment

General Richards: “If the Use of Lariam is Banned it Would Not Be Before Time”

Kim Sengupta, British armed forces set to ban most prescriptions of controversial anti-malarial drug Lariam, The Independent, 23 May 2016. A number of senior officers say that recognition of the dangerous side-effects that the use of Lariam  is long overdue. General … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , | Leave a comment

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 1

The New Mefloquine? Mefloquine is now well known to be neurotoxic, one of several synthetic quinolines able to cause acute psychotic reactions and/or a chronic central nervous system (CNS) toxicity syndrome in a significant proportion of people given these drugs … Continue reading

Posted in Clinical Drug Trials, Media, Research | Tagged , , , , , , , , , | 2 Comments

Congressman John Carter Proposes Support for Mefloquine Veterans by the U.S. Defense Centers of Excellence

The National Defense Authorization Act for Fiscal Year 2017 is currently being debated in U.S. Congress. During this debate Congressman John Carter (Texas) has proposed additional controls on the use of mefloquine by the Department of Defense, and expanding the Defense Centers … Continue reading

Posted in Advocacy, Research, Support | Tagged , , , , , , | Leave a comment

Philippa Tuckman – Lariam for Military Personnel: An Unacceptable Risk

The House of Commons Defence Committee will publish its report An acceptable risk? The use of Lariam for military personnel  on 24thMay. Having both given evidence to the inquiry and carefully considered the submissions of other witness, I am hopeful … Continue reading

Posted in Advocacy, Support | Tagged , , , , , , , , , | Leave a comment

CDC Staff Accused Injured U.S. Veteran of “Malingering” in Response to Official Drug Regulator Safety Warning on Mefloquine

FDA Black Box Warning In 2013 the U.S. Food and Drug Administration (FDA) issued a “black box” warning regarding the safety of the anti-malarial drug mefloquine. This is the most serious warning issued by the FDA, which in this case … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , , , , , , , | Leave a comment

British Parliamentary Inquiry Report on the Use of Lariam™ (Mefloquine) for Military Personnel to be Published on 24 May 2016

The British Parliament’s Defence Select Committee is publishing its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016 at 00.01am. Report This is the Committee’s Fourth Report of Session 2015–16 (HC 567) and it can … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Our Stories | Tagged , , , , , , , , , , , , | 1 Comment

Former Health Canada Official: “It’s High Time We Stopped Pretending Mefloquine Was Used Safely”

The federal government should recognize the anti-malaria drug mefloquine was not used safely in a trial during the fateful Somalia mission and address veteran concerns, a former top Health Canada bureaucrat says. The defence and health departments failed to do their … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Uncategorized | Tagged , , , , , , , | Leave a comment

Featured Research (2001) – C. Even, S. Friedman & K. Lanouar, Bipolar Disorder After Mefloquine Treatment

Case report of bipolar disorder in a patient with no personal of family history of psychiatric disorders,  presumably induced by mefloquine. Also see the extensive list of mefloquine related neurological and psychiatric case reports on our research page. C. Even, … Continue reading

Posted in Research | Tagged , , , , | Leave a comment